[go: up one dir, main page]

AU2020903624A0 - Methods and agents for the treatment of ocular disease - Google Patents

Methods and agents for the treatment of ocular disease

Info

Publication number
AU2020903624A0
AU2020903624A0 AU2020903624A AU2020903624A AU2020903624A0 AU 2020903624 A0 AU2020903624 A0 AU 2020903624A0 AU 2020903624 A AU2020903624 A AU 2020903624A AU 2020903624 A AU2020903624 A AU 2020903624A AU 2020903624 A0 AU2020903624 A0 AU 2020903624A0
Authority
AU
Australia
Prior art keywords
agents
treatment
methods
ocular disease
ocular
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
AU2020903624A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Implicit Bioscience Ltd
Original Assignee
Implicit Bioscience Ltd
Filing date
Publication date
Application filed by Implicit Bioscience Ltd filed Critical Implicit Bioscience Ltd
Publication of AU2020903624A0 publication Critical patent/AU2020903624A0/en
Priority to EP21876765.5A priority Critical patent/EP4225796A4/en
Priority to JP2023546368A priority patent/JP2023545579A/en
Priority to PCT/AU2021/051173 priority patent/WO2022073072A1/en
Priority to AU2021356298A priority patent/AU2021356298A1/en
Priority to KR1020237015441A priority patent/KR20230086713A/en
Priority to IL301762A priority patent/IL301762A/en
Priority to CN202180082106.9A priority patent/CN116710135A/en
Priority to US17/678,861 priority patent/US11618782B2/en
Priority to US18/160,355 priority patent/US12258390B2/en
Pending legal-status Critical Current

Links

AU2020903624A 2020-10-07 2020-10-07 Methods and agents for the treatment of ocular disease Pending AU2020903624A0 (en)

Priority Applications (9)

Application Number Priority Date Filing Date Title
EP21876765.5A EP4225796A4 (en) 2020-10-07 2021-10-07 METHODS AND MEANS FOR THE TREATMENT OF EYE DISEASES
JP2023546368A JP2023545579A (en) 2020-10-07 2021-10-07 Methods and drugs for the treatment of eye diseases
PCT/AU2021/051173 WO2022073072A1 (en) 2020-10-07 2021-10-07 Methods and agents for the treatment of ocular disease
AU2021356298A AU2021356298A1 (en) 2020-10-07 2021-10-07 Methods and agents for the treatment of ocular disease
KR1020237015441A KR20230086713A (en) 2020-10-07 2021-10-07 Methods and formulations for the treatment of eye diseases
IL301762A IL301762A (en) 2020-10-07 2021-10-07 Methods and materials for the treatment of eye diseases
CN202180082106.9A CN116710135A (en) 2020-10-07 2021-10-07 Methods and reagents for treating ocular diseases
US17/678,861 US11618782B2 (en) 2020-10-07 2022-02-23 Methods and agents for the treatment of ocular disease
US18/160,355 US12258390B2 (en) 2020-10-07 2023-01-27 Methods and agents for the treatment of ocular disease

Publications (1)

Publication Number Publication Date
AU2020903624A0 true AU2020903624A0 (en) 2020-10-29

Family

ID=

Similar Documents

Publication Publication Date Title
EP3955937A4 (en) Compounds and methods for the treatment of ocular disorders
WO2008029276A3 (en) Compositions and methods for the treatment of ophthalmic disease
EP3902525A4 (en) Ophthalmic pharmaceutical compositions and methods for treating ocular surface disease
EP4090658A4 (en) Therapeutic agents and methods of treatment
AU2021381495A9 (en) Formulations and methods for treating conditions of the eye
EP3955926A4 (en) Compounds and methods for the treatment of ocular disorders
IL287802A (en) Compositions and methods for treatment of ocular diseases
EP4054713A4 (en) Compositions and methods for treatment or prevention of skin diseases and disorders with lekti
EP3740592A4 (en) Methods and compositions for the treatment of vascular disease
PT3861985T (en) Compositions and methods for treating ocular diseases
EP4232458A4 (en) Compounds and methods for the treatment of ocular disorders
EP3538083A4 (en) Formulations for the treatment of ocular surface diseases and related methods
EP3852722A4 (en) Compositions and methods for the treatment of parkinson's disease
EP4100404A4 (en) Methods and compounds for the treatment of genetic disease
EP3691654A4 (en) Ophthalmic pharmaceutical compositions and methods for treating ocular surface disease
EP4010075A4 (en) Methods for the treatment of apoc3-related diseases and disorders
EP4146664A4 (en) Heterodimer compositions and methods for the treatment of ocular disorders
AU2020903624A0 (en) Methods and agents for the treatment of ocular disease
EP3813794A4 (en) Ophthalmic compositions and methods for the treatment of eye disorders
EP4161527A4 (en) Compounds and methods for the treatment of eye disorders
TWI799923B (en) Use of thioimidazolidinone drugs in the treatment of covid-19 disease
EP3860592A4 (en) Ophthalmic compositions and methods for the treatment of skin diseases and eye diseases
EP3823603A4 (en) Ophthalmic compositions and methods for the treatment of eye disorders and skin diseases
EP3914263A4 (en) Methods and compositions for the treatment and prevention of ocular diseases and conditions
EP3946418A4 (en) Compositions and methods for treating ocular disease